英文【EFPIA】2025年：制药行业的数字

www.efpia.euThe Pharmaceutical Industry in FiguresKey Data 2025EFPIA Key Data | 20252Thanks to advances in science and technology, the research-based pharmaceutical industry is going through an exciting era in medicines development. Research methods are evolving and we have many promising prospects on the horizon, with ground-breaking cell and gene therapies being increasingly available*. The innovative pharmaceutical industry is driven by, and drives, medical progress. It aims to turn fundamental research into innovative treatments that are widely available and accessible to patients. Already, the industry has contributed to significant improvements in patient well-being. Today’s European citizens can expect to live up to 30 years longer than they did a century ago. Some major steps in biopharmaceutical research, complemented by many smaller steps, have allowed for reductions in mortality, for instance from HIV/AIDS-related causes and several cancers. High blood pressure and cardiovascular diseases can be controlled with antihypertensive and cholesterol-lowering medicines; knee or hip replacements prevent patients from immobility; and some cancers can be controlled – or even cured – with the help of new targeted treatments. European citizens can expect not only to live longer, but to live better quality lives. Yet major hurdles remain, including Alzheimer’s, Multiple Sclerosis, many cancers, and rare diseases. THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESSSource: HIV/AIDS surveillance in Europe 2024 (2023 data), WHO European Region & European Centre for Disease Prevention and Control (ECDC), 28 November 2024* https://www.efpia.eu/media/hibdosn5/2024-pipeline-review.pdfTOTAL NUMBER OF DEATHS AMONG AIDS CASES IN EUROPE (TOTAL EU/EEA)050010001500200020222023201420152016201720182019202020211792663770874890102611721219153815433INDUSTRY (EFPIA total) 2000 2010202020232024Production127,504197,359322,554405,701440,000 (e)Exports (1) (2)90,935276,357509,828661,559705,000 (e)Imports68,841204,824347,124468,032485,000 (e)Trade balance22,09471,533162,704193,527220,000 (e)R&D expenditure17,84927,92038,73652,37355,000 (e)Employment (units)556,506699,059850,928940,555950,000 (e)R&D employment (units)88,397116,360121,717123,535130,000 (e)Total pharmaceutical market value at ex-factory prices89,449 153,685215,902274,545295,000 (e)Payment for pharmaceuticals by statutory health insurance systems (ambulatory care only) 76,909129,706143,762172,689185,000 (e)THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO THE EUROPEAN ECONOMYAs well as driving medical progress by researching, developing and bringing new medicines that improve health and quality of life for patients around the world, the research-based pharmaceutical industry is a key asset of the European economy. It is one of Europe’s top performing high-technology sectors. Values in € million unless otherwise stated(1) Data relate to EU-27, Norway, Switzerland and United Kingdom si